Skip to main content
. 2023 Jul 27;18:e46. doi: 10.15420/ecr.2023.04

Table 3: Healthcare Usage at 3 Years in the EARLY-AF Trial.

ER Visit Hospitalisation Cardioversion Non-protocol Ablation
RR 0.84, 95% CI [0.59–1.20] RR 0.3, 95% CI 1 [0.14–0.66] RR 0.68, 95% CI [0.36–1.29] RR 0.41, 95% CI [0.28–0.61]
Ablation 40 (26.0%)
versus
AAD 46 (30.9%)
Ablation 8 (5.2%)
versus
AAD 25 (16.8%)
Ablation 14 (9.1%)
versus
AAD 20 (13.4%)
Ablation 27 (17.5%)
versus
AAD 63 (42.3%)

AAD = antiarrhythmic drugs.